Tag Archive for: cell and gene therapy

This Week in Cell and Gene Therapy: 11 New Developments to Know (September 12, 2022)

There have been a number of recent developments in cell and gene therapy, as detailed in our bimonthly newsletter, Cell and Gene Therapy Business Outlook. Kite Pharma, a Gilead Company based in Santa Monica, CA, has announced that the European Commission (EC) has granted approval for its chimeric antigen receptor (CAR) T cell therapy Tecartus […]

This Week in Cell and Gene Therapy: 8 New Developments to Know (August 22, 2022)

There have been a number of recent developments in cell and gene therapy, as detailed in our bimonthly newsletter, Cell and Gene Therapy Business Outlook. Prescient Therapeutics, a clinical stage oncology company based in Melbourne, Australia, has signed a five-year manufacturing agreement with Q-Gen Cell Therapeutics, a specialist cell therapy manufacturer based at the QIMR […]

This Week in Cell and Gene Therapy: 10 New Developments to Know (August 9, 2022)

This Week in Cell and Gene Therapy: 10 New Developments to Know (July 11, 2022)

This Week in Cell and Gene Therapy: 14 New Developments to Know (June 27, 2022)

This Week in Cell and Gene Therapy: 12 New Developments to Know (June 13, 2022)

This Week in Cell and Gene Therapy: 14 New Developments to Know (May 23, 2022)

This week in Cell and Gene Therapy: 14 New Developments to Know (May 9, 2022)

There have been a number of recent developments in cell and gene therapy, as detailed in our bimonthly newsletter, Cell and Gene Therapy Business Outlook. The U.S. FDA has lifted clinical holds on two Phase III clinical studies evaluating gene therapies being developed by Pfizer, based in New York, NY. On April 28th, Pfizer announced […]

$54.4 Billion in Deals and Counting: Analyzing Three Quarters of Cell and Gene Therapy Funding

Over 54 BN across funding mechanisms.  Private, VC, SPAC and and IPO Over 20Billion The enormous amount of funding presages confidence in discoveries of future marketable products as well as platforms in cell and gene therapy.  With an aggressive third quarter 2021 for funding, it is worthwhile to total and assess where we are.  In […]

Infographic: Cell and Gene Therapy Contract Manufacturing Organizations (CMOs)

Learn more about this important market by subscribing to CELL AND GENE THERAPY BUSINESS OUTLOOK, a twice-monthly publication from the leaders at Kalorama Information. This is an exciting time for the cell and gene therapy industry. Its products are transforming the treatment of cancers and genetic diseases, as well as a host of other illnesses […]